Skip to main content
logo
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
146.79
-0.97 (-0.65%)
Sep 1, 2026, 1:19 PM EDT - Market open

Protagonist Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
82.91-130.15275.19-78.96-127.39-125.55
Depreciation & Amortization
1.541.282.93.313.372.78
Loss (Gain) From Sale of Investments
-5.09-7.22-8.88-4.57-0.551.83
Stock-Based Compensation
49.8245.9737.5529.2924.216.4
Other Operating Activities
1.321.58-0.19--
Change in Accounts Receivable
5.51164.88-155-9.991.560.86
Change in Accounts Payable
0.213.720.84-2.872.05-1.39
Change in Unearned Revenue
-10.4-21.0230.57--1.6-12.88
Change in Income Taxes
--2.692.69---
Change in Other Net Operating Assets
5.391.31-1.71-6.65-9.7710.09
Operating Cash Flow
131.257.67184.15-70.24-108.14-107.87
Operating Cash Flow Growth
231.79%-68.68%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.62-1.59-1.36-0.61-0.8-1.1
Investment in Securities
79.34-47.74-298.13-38.6592.26-14.76
Investing Cash Flow
78.72-49.33-299.48-39.2691.47-15.86

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
41.6123.3426.45171.2519130.11
Repurchase of Common Stock
--0.48-0.6-0.77-0.19-0.19
Other Financing Activities
----0.03-
Financing Cash Flow
41.6122.8625.85170.4818.84129.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-----0.09-0.13
Net Cash Flow
251.5331.2-89.4860.982.086.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
130.5856.08182.8-70.85-108.93-108.97
Free Cash Flow Growth
251.98%-69.32%----
Free Cash Flow Margin
46.31%121.87%42.08%-118.08%-409.81%-398.31%
Free Cash Flow Per Share
1.940.882.81-1.25-2.22-2.35
Levered Free Cash Flow
96.15105.6265.11-43.31-60.37-61.59
Unlevered Free Cash Flow
96.15105.6265.11-43.31-60.37-61.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
3.693.691.53---
Change in Working Capital
0.71146.21-122.61-19.51-7.77-3.31
SEC Filings: 10-K · 10-Q